Breast cancers regroup many heterogeneous diseases with different prognoses and sensibilities to treatment and can be categorized by their receptor expression: hormone receptors (HRs), namely the estrogen (ER) and progesterone (PR) receptors, and the human epidermal growth factor receptor 2 (HER2) [5]. This evidence concerns the gene ERBB2 and breast carcinoma.